Enhanced sensitivity to cholecystokinin tetrapeptide in panic disorder. Clinical and behavioral findings.
about
Pharmacological evaluation of IQM-95,333, a highly selective CCKA receptor antagonist with anxiolytic-like activity in animal modelsThe Deakin/Graeff hypothesis: focus on serotonergic inhibition of panic.Neuroimaging in anxiety disorders.CCK and NPY as anti-anxiety treatment targets: promises, pitfalls, and strategiesInteraction between the cholecystokinin and endogenous cannabinoid systems in cued fear expression and extinction retentionNeuropeptide regulation of fear and anxiety: Implications of cholecystokinin, endogenous opioids, and neuropeptide Y.Human models as tools in the development of psychotropic drugsElevated cholecystokininergic tone constitutes an important molecular/neuronal mechanism for the expression of anxiety in the mouse.Modelling anxiety in humans for drug developmentEvaluation of the CCK-4 model as a challenge paradigm in a population of healthy volunteers within a proof-of-concept study.Impact of state and trait anxiety on the panic response to CCK-4.Changes in central sodium and not osmolarity or lactate induce panic-like responses in a model of panic disorderEffects of citalopram treatment on behavioural, cardiovascular and neuroendocrine response to cholecystokinin tetrapeptide challenge in patients with panic disorderNeuronal network of panic disorder: the role of the neuropeptide cholecystokinin.Pentagastrin induced panic attacks: enhanced sensitivity in panic disorder patients.The cholecystokinin-B receptor antagonist CI-988 failed to affect CCK-4 induced symptoms in panic disorder patients.Cholecystokinin: a multi-functional molecular switch of neuronal circuits.Cholecystokinin-induced anxiety in rats: relevance of pre-experimental stress and seasonal variations.Studies of pharmacokinetic and pharmacodynamic properties of isoallopregnanolone in healthy women.Pentagastrin-induced release of free fatty acids in healthy volunteers and patients with panic disorder: effect of pretreatment with ethinyl estradiol.Of monkeys and men: vervets and the genetics of human-like behaviorsExperimental panic provocation in healthy man-a translational role in anti-panic drug development?Does the panic attack activate the hypothalamic-pituitary-adrenal axis?Ancient Anxiety Pathways Influence Drosophila Defense BehaviorsCandidate genes for panic disorder: insight from human and mouse genetic studies.The CCK-system underpins novelty-seeking behavior in the rat: gene expression and pharmacological analyses.Prefrontal cortical circuit for depression- and anxiety-related behaviors mediated by cholecystokinin: role of ΔFosB.Advances in molecular genetics of panic disorder.Biological markers for anxiety disorders, OCD and PTSD: A consensus statement. Part II: Neurochemistry, neurophysiology and neurocognition.The cholecystokinin hypothesis of panic and anxiety disorders: a review.The cholecystokinin hypothesis of anxiety and panic disorder.CCK, schizophrenia, and anxiety. CCK-B antagonists inhibit the activity of brain dopamine neurons.Two faces of cholecystokinin: anxiety and schizophrenia.Antidepressant-like effects of CCKB antagonists in mice: antagonism by naltrindole.Pentagastrin has panic-inducing properties in obsessive compulsive disorder.Impairment of stress adaptive behaviours in rats by the CCKA receptor antagonist, devazepideAssociation studies of the CT repeat polymorphism in the 5' upstream region of the cholecystokinin B receptor gene with panic disorder and schizophrenia in Japanese subjects.Emotional perception modulated by an opioid and a cholecystokinin agonist.Cholecystokinin induces cerebral vasodilatation via presynaptic CCK2 receptors: new implications for the pathophysiology of panic.Panic-related responses to pentagastrin, flumazenil, and thyrotropin-releasing hormone in healthy volunteers.
P2860
Q24673072-7B525CAB-8692-4DD4-B946-C0BB581AE2C4Q27022602-D0113DBC-B19A-4B46-9F90-5F549741912BQ27686845-9E69EC2F-AB17-4441-B331-6CA638D282A6Q28243274-BDA9FA2F-976B-46AC-AAD2-E720DBA56705Q30392035-31117035-032E-4048-A58B-1BAF2033821AQ30453815-C53C5BEE-DADE-4E1C-8AAE-8F279F508D7AQ30473426-F8B7A700-EB35-4E99-BB8B-9E20CF807686Q30476895-690636B0-5AAA-48A6-8417-796038DA514BQ30493993-016680D6-6937-4E6F-B4AA-32BA6462196EQ33275210-06BAEDFD-1798-4016-ABD0-9187863FF6DAQ33328518-7F7C7FAC-8196-4759-8B35-BB34B95B9588Q33793925-530C7804-5461-43BC-B069-909143FA6C7AQ33921982-2795642E-799B-48E8-821A-010F266E5AAFQ34272451-30FCECD9-013E-4B53-B97A-2778658C9093Q34318557-47DBA4C5-4C60-4234-BD2D-02523B09840AQ34420283-8A944FBB-15F8-490C-9F87-C2A52C876067Q34420892-F7E0BB01-FCA1-4E4D-A9B8-F2EED06603E0Q34464184-AE3FBB13-2646-4AAC-8C89-BB7982003890Q34864910-0FAFFCD9-18FC-4AF1-AA71-D0BD1B06CC66Q35101567-E52B8686-655C-413E-BF1B-B71D91856872Q35249582-4DD6A3D0-06AA-4FCA-AA5E-629AB69C2A89Q35686873-D792FEFA-5022-461A-B800-34F6CA555C0CQ36243043-3826A11D-E974-429D-A9D9-B4552658F5F5Q36783145-2E13309B-D410-485F-BB90-B219273E708BQ36837317-168E1695-4A8F-4400-A0D7-B1EC9B6AFFFFQ37252310-67494355-CFF6-4A54-AD35-C25330FD851AQ37633608-342FCEF3-5B1B-4071-AA24-A45B52408979Q37667843-D8312650-318C-4B07-80A1-1E3C22F4B517Q37686937-08302969-F690-44F5-9252-4606F231BB79Q37980110-B2D54DA8-2D3F-4459-91D0-972A9B7750F3Q40753314-8B99E195-8465-4FA0-B41C-1B26E498A5CDQ40753318-E61101AF-201E-4B2F-8ECC-B6371B513880Q41061878-3D2E2C8E-0BD8-4B7F-8137-BFDF40DE2F65Q41973984-3BED2577-F93E-4791-B70A-9BC15FBE8966Q42552995-869A48EA-4B2B-40A3-8348-4A8ED6FC1942Q42704380-AE859AC4-EF68-465B-92D9-5D3C03A2C3F3Q43861876-50394C8D-BBC2-4BC3-8B6F-9EA909F47693Q44337191-06FB9F55-D8A6-42FC-8F1E-C15F93FFAF60Q44351075-8E82E9AE-46BF-4EF1-BFD4-FB8DE9D744F5Q44351504-97902A7F-402D-45A9-B2C3-863D43AD6B50
P2860
Enhanced sensitivity to cholecystokinin tetrapeptide in panic disorder. Clinical and behavioral findings.
description
1991 nî lūn-bûn
@nan
1991年の論文
@ja
1991年論文
@yue
1991年論文
@zh-hant
1991年論文
@zh-hk
1991年論文
@zh-mo
1991年論文
@zh-tw
1991年论文
@wuu
1991年论文
@zh
1991年论文
@zh-cn
name
Enhanced sensitivity to cholec ...... nical and behavioral findings.
@en
type
label
Enhanced sensitivity to cholec ...... nical and behavioral findings.
@en
prefLabel
Enhanced sensitivity to cholec ...... nical and behavioral findings.
@en
P2093
P1433
P1476
Enhanced sensitivity to cholec ...... nical and behavioral findings.
@en
P2093
P304
P356
10.1001/ARCHPSYC.1991.01810310021005
P407
P577
1991-07-01T00:00:00Z